Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ocimum Biosolutions
AddedFeb 15, 2024
UpdatedJun 18, 2026
Ocimum Biosolutions

Ocimum Biosolutions

Acquired

Ocimum Biosolutions: A genomics firm offering GLP-compliant microarray services and life science solutions.

HQ
Gaithersburg, MD, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

Ocimum Biosolutions, founded with a mission to advance genomics research, offers GLP-compliant microarray services, reference databases, and comprehensive life science solutions. The company focuses on providing integrated global genomics outsourcing solutions, including Laboratory Information Management Systems (LIMS) and biologics data management tools. Ocimum's products and services cater to the needs of laboratories and research institutions seeking efficient data and sample management, as well as advanced genomic data analysis.

Notable figures associated with Ocimum Biosolutions include its leadership team and key investors who have supported its growth in the genomics sector. The company has achieved significant milestones, such as developing the Sciantis tool for biologics process tracking and analytics, and establishing a robust suite of gene expression and toxicogenomics databases. Ocimum's impact is evident in its contribution to streamlining laboratory operations and enhancing the precision of genomic research, thereby supporting scientific advancements in life sciences.

Ocimum Biosolutions - Similar Companies

BioDatomics logo

BioDatomics

biodatomics.com

OmicsCraft logo

OmicsCraft

omicscraft.com

CyOmics logo

CyOmics

Ovation logo

Ovation

ovation.io

eBioinformatics logo

eBioinformatics

Insightful Science logo

Insightful Science

Omix.ai logo

Omix.ai

CapForce logo

CapForce

opgen.com

Bioinfoexperts logo

Bioinfoexperts

bioinfox.com

Bioinformatics logo

Bioinformatics

bioinfoinc.com

Element Biosciences logo

Element Biosciences

Genometry logo

Genometry

Centrillion Technologies logo

Centrillion Technologies

Arrayit logo

Arrayit

arrayit.com

Toma Biosciences logo

Toma Biosciences

tomabio.com

Ocimum Biosolutions - Quick Facts

Who are Ocimum Biosolutions' competitors?

Companies similar to Ocimum Biosolutions include BioDatomics, OmicsCraft, CyOmics and Ovation.

When was Ocimum Biosolutions founded?

Ocimum Biosolutions was founded in 2000.

Where is Ocimum Biosolutions' headquarters located?

Ocimum Biosolutions' headquarters is located in Gaithersburg, MD, US.

When was Ocimum Biosolutions' last funding round?

Ocimum Biosolutions' most recent funding round was for $8M (USD) in January 2011.

How much has Ocimum Biosolutions raised to-date?

As of Jan 18, 2011, Ocimum Biosolutions has raised a total of $31.5M (USD).

Ocimum Biosolutions - Classification

Industry
  • Professional Service Companies
Technology
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Genomics
  • Microarray Services
Tags
  • Biotech
  • Data
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software